ACRO optimistic about changes; Oxford spinout raises $16.1M for gene analysis;

> As federal regulators move to increase the amount of data that must be disclosed on, CROs have some outstanding questions but are generally optimistic about the proposed changes, ACRO's John Lewis told Outsourcing-Pharma. More

> Genomics, an Oxford spinout offering genome data analysis, has raised $16.1 million to develop its platform. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.